Enterprise Value
245.5M
Cash
34.53M
Avg Qtr Burn
-1.615M
Short % of Float
4.32%
Insider Ownership
5.18%
Institutional Own.
78.59%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Avance® Nerve Graft Details Nerve discontinuities | BLA Submission |